Diligence memo · auto-generated · as of July 3, 2026

Cohere Health Inc.

Cohere Health Inc. looks over-valued against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 2.2× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Cohere Health Inc. operates in Healthtech, based in BOSTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Cohere Health Inc. has raised $166M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $90M on 2025-05-07.

Most recent recorded round closed around 2025-05-07.

Valuation (modeled)modeled

Provath models Cohere Health Inc. at approximately $605M (range $327M–$817M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.83× the median modeled value of Series C Healthtech companies in 2025–2027 (19 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 25 months.

Last raise 14 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 2.2× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 98% of Healthtech peers (2138 compared).

Modeled value ranks above 94% of those peers.

Closest niche peers: Thyme Care, Inc., All Inspire Health, Inc., Harbor Health Team Inc., Apreo Health, Inc., 4C Medical Technologies, Inc..

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.